Updates and perspectives from our industry experts, scientists and product leaders.
Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.
Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.
We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.
Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.
Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.
Jill Roughan, PhD
February 1, 2023
As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.
Nick Ketz, PhD
January 31, 2023
DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.
Claire Aldridge, PhD
January 17, 2023
Why are natural history studies important in cell and gene therapy development? Hear from our Chief Strategy Officer, Claire Aldridge, PhD on the importance of these studies and the need for effective data capture to make the most of them.
December 27, 2022
Read here for an introduction to the emerging field of computational life sciences and its broad impact and applications in solving challenging research and clinical problems.
December 13, 2022
Metagenomics studies and sophisticated computational tools advance disciplines from basic research to healthcare. Find out more in our blog.
ChatGPT
December 7, 2022
With AI becoming not just inextricable but central for both science and software, we thought it fitting and worthwhile to utilize creative AI tools to see what 2023 might have in store for cell and gene therapy. Hence, our guest author is none other than OpenAI's ChatGPT.
November 29, 2022
The ability to interpret data is crucial to advancing cell and gene therapy research. Read on to hear how researchers are presenting data in an accessible way.
November 15, 2022
The power of deep learning for discovering and developing cell and gene therapies is undeniable. Learn how to implement it with these 10 actionable tips.
November 8, 2022
Sequencing technologies have seen many remarkable innovations over the last decade and shows no signs of slowing down. Read here for emerging trends.
October 25, 2022
Hear from Karlie, our Senior Engineer, on driving diversity, equity, inclusion and belonging (DEIB) in tech and more.
October 20, 2022
Deciding between purchasing bioinformatics software or building your own pipeline? Check out the opportunities and challenges of each.
October 3, 2022
Did you miss the 2022 iC3 Life Science Summit? No worries, read here for the top take-aways by Form’s Chief Strategy Officer.
May 3, 2023
Sasha Maslova
April 18, 2023
Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.
Austin Day, PhD
March 22, 2023
Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.
Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.